Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2015 08:23 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Quarter 1 Results -- EPS 17.4 Cents Dividend of 22 Cents

DUBLIN, Ireland, April 30, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
April 23, 2015 05:13 ET | Source: Trinity Biotech plc

Trinity Biotech plc to Announce First Quarter Fiscal Year 2015 Financial Results

DUBLIN, Ireland, April 23, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
April 09, 2015 13:05 ET | Source: Trinity Biotech plc

Trinity Biotech plc Closes Offering of $115 Million of 4.00% Exchangeable Senior Notes Due 2045, Including Exercise in Full of Option to Purchase Additional Notes

DUBLIN, Ireland, April 9, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
March 25, 2015 12:21 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Filing of 2014 Annual Report

DUBLIN, March 25, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today...
March 03, 2015 08:47 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Results for Q4 and Fiscal Year 2014

DUBLIN, Ireland, March 3, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
February 25, 2015 10:44 ET | Source: Trinity Biotech plc

Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2014 Financial Results

DUBLIN, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...
February 23, 2015 10:18 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Recommencement of US Clinical Trials on Its Point-of-Care, High Sensitivity Troponin I Product

DUBLIN, Ireland, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
December 16, 2014 11:26 ET | Source: Trinity Biotech plc

Trinity Biotech Announces CLIA Waiver of Rapid Syphilis Test

DUBLIN, Ireland, Dec. 16, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
October 23, 2014 09:01 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Quarter 3 Financial Results and Temporary Suspension of Meritas Troponin Trials

DUBLIN, Ireland, Oct. 23, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
October 06, 2014 05:45 ET | Source: Trinity Biotech plc

Trinity Biotech plc to Announce Third Quarter Fiscal 2014 Financial Results

DUBLIN, Oct. 6, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...